Inhaled Technosphere Insulin in Children with Diabetes: The INHALE-1 Extension Study

20260 citationsJournal Article

Authors

Roy W. Beck · Jaeb Center for Health Research

Lauren Kanapka · Jaeb Center for Health Research

Roshanak Monzavi · Children's Hospital of Los Angeles

Steven M. Willi · Children's Hospital of Philadelphia

Michael Tansey · Iowa Diabetes and Endocrinology Research Center

Jamie Wood · Rainbow Babies & Children's Hospital

Anna Cymbaluk

Abstract

The INHALE-1 extension phase showed no safety concerns. Although HbA1c levels deteriorated slightly during the study, in view of the safety profile and increased patient satisfaction in the RCT portion of the trial, TI may be a useful treatment option for some pediatric patients with diabetes, particularly for those who choose not to or are unable to use an AID system.

Topics & Keywords

Inhalation and Respiratory Drug Delivery Asthma and respiratory diseases Cystic Fibrosis Research Advances

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Technology & Therapeutics

DOI: 10.1177/15209156261420176

Field-Weighted Citation Impact: 0.00